Biotech Cocrystal Pharma Provides Business Update and Reports Third Quarter 2026 Financial Results November 16, 2026
Biotech HUTCHMED Announces Expanded Coverage on National Reimbursement Drug List for ELUNATE® and ORPATHYS® November 16, 2026
Biotech Reviva Reports Third Quarter 2026 Financial Results and Recent Business Highlights November 13, 2026
Biotech Rakovina Therapeutics Expands Strategic Engagement with Renowned AI Drug Discovery Pioneer Dr. Artem Cherkasov November 12, 2026
Biotech Pharming to participate in fireside chat at Jefferies Global Healthcare Conference in London November 11, 2026
Biotech Immutep Further Expands United States Patent Estate for Efti-Based Combination Therapies November 11, 2026
Biotech Neuronetics Announces Pricing of $30 Million Underwritten Public Offering of Common Stock November 11, 2026
Biotech Mineralys Therapeutics Presents New Late-Breaking Data from Transform-HTN Open-Label Extension Trial of Lorundrostat in Hypertension at AHA Scientific Sessions 2026 November 9, 2026
Biotech IMP761 Late-Breaking Abstract at ACR Convergence 2026 Highlights Statistically Significant & Exposure-Dependent Inhibition of T-Cell-Driven Immune Responses November 9, 2026